Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
Just noticed XPEV has been struggling lately. The stock dropped about 1% today while the broader market actually gained ground, which is interesting. Over the past month it's down over 11%, significantly underperforming even its own auto sector. The ADR is trading at $17.54 currently.
What's catching my attention is the valuation situation. This stock is priced at a forward P/E of 109, which is way above the industry average of 13.37. That's a pretty steep premium to pay right now. The PEG ratio is sitting at 2.81 versus the sector average of 1.31, so growth expectations are already baked in.
On the positive side, earnings estimates are getting revised upward. Revenue is projected to hit $3.32 billion next quarter, up 50% year-over-year, and full-year revenue could reach $10.99 billion, nearly doubling from last year. So there's definitely growth happening. The question is whether that growth justifies the current valuation of this ADR.
The stock has a Zacks Rank of 2 (Buy), but honestly the valuation disconnect is something to watch. If earnings don't deliver at the expected pace, this stock could face pressure. Worth monitoring through the next earnings call to see if the company can actually justify that premium valuation.